Rapidol Arnica Tablets recalled due to manufacturing deviations
Pharmadel is recalling 6,048 bottles of Rapidol Arnica Tablets homeopathic medicine due to current good manufacturing practice (cGMP) deviations. The recall affects bottles with lot EAT-01, expiration date March 27, distributed in Delaware.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as Class II. The source text identifies cGMP deviations as the reason but does not report any actual illnesses, injuries, or hospitalization; the hazard is process-related and precautionary in nature, supporting a Moderate severity rating.
Plain-English summary
Pharmadel, LLC is recalling Rapidol Arnica Tablets, a homeopathic medicine sold in 100-count bottles with NDC 55758-405-99. The recall involves 6,048 bottles with lot number EAT-01 and expiration date March 27, distributed in Delaware.
The recall was initiated due to current good manufacturing practice (cGMP) deviations identified during manufacturing operations. This is a voluntary recall initiated by the firm and classified by the FDA as Class II.
Consumers who have purchased this product should stop using it. The recall was terminated as of January 8, 2026.
The recalled product
- Product
- Rapidol Arnica Tablets, Homeopathic Medicine, 100-count bottle, Distributed by: Pharmadel, New Castle, DE 19720, NDC 55758-405-99
- Manufacturer
- Pharmadel, LLC
- Category
- Drug — Homeopathic Medicine
- Hazard
- Affected units
- 6,048
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot
- expiry: EAT-01
- EXP: MAR 27
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 6 recalled by Pharmadel, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Pharmadel, LLC
See all →- ModerateKingskin Salicylic Acid Wart Removal Recall Due to cGMP Deviations
FDA (Drugs) · 2025-04-30
- ModerateDoloDent Maximum Strength Toothache Drops Recalled for cGMP Deviations
FDA (Drugs) · 2025-04-30
- ModerateUrodel Homeopathic Urinary Tract Infection Relief Tablets Recalled
FDA (Drugs) · 2025-04-30
- ModerateRapidol Arnica Gel topical homeopathic medicine recalled for manufacturing violations
FDA (Drugs) · 2025-04-30
- ModerateDoloEar Homeopathic Earache Drops Recalled for cGMP Deviations
FDA (Drugs) · 2025-04-30
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- ModerateRapidol Hydrocortisone 1% Anti-Itch Cream Recalled for CGMP Deviations
FDA (Drugs) · 2025-05-28
- ModerateDrug Recall: Aripiprazole 5mg Tablets Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-04-12
- HighRopinirole 0.5 mg tablets recalled for manufacturing quality deviations
FDA (Drugs) · 2023-04-12
- ModerateDrug Recall: Tadalafil 5 mg Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2023-04-12
- ModerateDrug recall: Kanjo homeopathic pain relief cream with arnica due to manufacturing deviations
FDA (Drugs) · 2023-07-05
- HighRopinirole tablets recalled due to manufacturing practice deviations
FDA (Drugs) · 2023-03-08